Lori Johnston - Amgen Insider

Amgen Inc -- USA Stock  

USD 186.11  0.18  0.10%

Senior Vice President - Human Resources

Ms. Lori A. Johnston serves as Senior Vice President of the Company. From October 2012 to December 2016, Ms. Johnston was Executive Vice President and Chief Administrative Officer of Celanese Corporationrationration. From February 2006 to September 2012, Ms. Johnston served in a series of progressive leadership roles at Amgen, with her last position being Vice President, Human Resources. Prior to joining the Company, Ms. Johnston held human resources and other positions at Dell Inc.
Age: 51  President Since 2016      
805 447-1010  www.amgen.com

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Robert FordAbbott Laboratories
2015
Andrew LaneAbbott Laboratories
2015
Blaise ColemanEndo International plc
2016
Timothy ErnstBio Rad Laboratories Inc
2016
Roger BirdAbbott Laboratories
2015
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Charles FoltzAbbott Laboratories
2013
Murthy SimhambhatlaAbbott Laboratories
2013
Deepak NathAbbott Laboratories
2015
Thomas FrinziAbbott Laboratories
2016
Jonathon KellermanAllergan plc
2014
Scott WhiteAbbott Laboratories
2013
Stephen FussellAbbott Laboratories
2013
Philippe SchaisonAllergan plc
2015
Ian SmithVertex Pharmaceuticals Incorpor
2017
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Shawn SoderbergBio Rad Laboratories Inc
2013
Eric FainAbbott Laboratories
2017
Paul SilvaVertex Pharmaceuticals Incorpor
2011
Michael RousseauAbbott Laboratories
2017
Brian LortieEndo International plc
N/A

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators